Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study

Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study

Abstract Background In Japan, freeze-dried live attenuated varicella-zoster vaccine is available for adults aged ≥50 years to prevent herpes zoster. However, limited evidence has been accumulated regarding vaccine safety for patients with underlying illnesses, who have been considered as the high-ri...

Full description

Bibliographic Details
Main Authors: Satoko Ohfuji, Kazuya Ito, Megumi Inoue, Motoki Ishibashi, Hiroko Kumashiro, Yoshio Hirota, Eiji Kayano, Naoshi Ota
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Infectious Diseases
Subjects:
Adverse events
Autoimmune diseases
Diabetes mellitus
Herpes zoster
Malignancy
Reactogenicity
Online Access:http://link.springer.com/article/10.1186/s12879-019-3719-7

Internet

http://link.springer.com/article/10.1186/s12879-019-3719-7

Similar Items